Eltrombopag Olamine recalls
The FDA has published 1 recall involving Eltrombopag Olamine since 2019. The latest was reported on 29 May 2019. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2019
Last 12 months0reported
Class I1100% of total
Ongoing0latest 29 May 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 100%Class II 0 0%Class III 0 0%
Why eltrombopag olamine is recalled
Companies
By year
All eltrombopag olamine recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Promacta (eltrombopag) 12.5 mg for Oral Suspension recalledPromacta | Novartis Pharmaceuticals | Other | Nationwide |
Should you stop taking Eltrombopag Olamine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.